Home > Income Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Revenue

    Back to Income Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹7,845 Cr₹7,767 Cr₹8,960 Cr₹6,969 Cr₹5,394 Cr

What is the latest Revenue of DIVIS LABORATORIES ?

The latest Revenue ratio of DIVIS LABORATORIES is ₹7,845 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹7,845 Cr
Mar2023₹7,767 Cr
Mar2022₹8,960 Cr
Mar2021₹6,969 Cr
Mar2020₹5,394 Cr

How is Revenue of DIVIS LABORATORIES Trending?

Years Revenue % Change
Mar2024 ₹7,845 Cr
1.00
Mar2023 ₹7,767 Cr
-13.31
Mar2022 ₹8,960 Cr
28.56
Mar2021 ₹6,969 Cr
29.20
Mar2020 ₹5,394 Cr -

Compare Revenue of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹151,439.9 Cr -2.3% 2.3% 57.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,395.0 Cr -3.6% -8.2% 5.5% Stock Analytics
CIPLA ₹119,252.0 Cr -0.4% 5.8% 1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹101,889.0 Cr -1.2% -9.8% 16.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,191.9 Cr -2.8% -2.7% -9.5% Stock Analytics
MANKIND PHARMA ₹94,909.6 Cr -3.6% -6.5% 6.4% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-2.3%

2.3%

57.6%

SENSEX

-2%

-2.3%

2.5%


You may also like the below Video Courses